drugset / Trial / NCT05305560
A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
RandomizedParallel-groupDouble-blindPrevention
Summary
A multicenter, randomized, double-blind, placebo-controlled, study to evaluate the efficacy and safety of oral ivermectin tablets versus placebo for COVID-19 prophylaxis
Timeline
- Start
- 2022-03-25
- Primary completion
- 2022-09-15
- Completion
- 2022-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 100 ug/kg | Oral |